Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
≤0.25 - 2 |
Zosyn |
371 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
0.25 - 4 |
Ampicillin (Omnipen) |
1601 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
≤0.25 - 8 |
Zosyn |
475 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
0.5 - 2 |
Teicoplanin (Targocid) |
463 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
0.5 - 4 |
GSQ1530 |
1060 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
0.5 - 4 |
RWJ-416457 |
189 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
1 - 2 |
Daptomycin (Cubicin) |
16 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
1 - 2 |
Vancomycin (Vancocyn, Lyphocin) |
1279 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
1 - 2 |
Vancomycin (Vancocyn, Lyphocin) |
248 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
1 - 2 |
Vancomycin (Vancocyn, Lyphocin) |
51 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
1 - 2 |
Vancomycin (Vancocyn, Lyphocin) |
189 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
1 - 4 |
Vancomycin (Vancocyn, Lyphocin) |
311 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
? - ? |
Cefmenoxime |
1389 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
? - ? |
Cefotaxime (Cephotaxime, Claforan) |
1389 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
? - ? |
S-3578 |
1111 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
4 |
0.125 - 4 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
248 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
4 |
0.25 - 4 |
Cefazolin (Ancef, Kefzol, Zolicef) |
248 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
4 |
0.25 - 8 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1464 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
8 |
0.25 - 8 |
Amikacin (Amikin) |
248 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
16 |
≤0.25 - 16 |
Ampicillin (Omnipen) |
186 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
32 |
0.12 - 64 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
396 |
Staphylococcus aureus (methicillin-susceptible) |
>1 |
>64 |
0.25 - >64 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
120 |
Staphylococcus aureus (methicillin-susceptible) |
1 |
64 |
0.5 - >64 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
178 |
Staphylococcus aureus (methicillin-susceptible) |
≤1.7 |
≤1.7 |
≤1.7 - 109 |
Neomycin (Mycifradin, Neo-Fradin) |
604 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
0.25 - 4 |
Oritavancin (LY333328) |
72 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
0.25 - 4 |
Oritavancin (LY333328) |
207 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
0.5 - 2 |
Vancomycin (Vancocyn, Lyphocin) |
463 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
≤0.5 - 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
475 |